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Access to Care and the Incidence of
End-Stage Renal Disease Due to Diabetes
MICHAEL M. WARD, MD, MPH
OBJECTIVE — Low socioeconomic status (SES) is associated with an increased risk of end-
stage renal disease (ESRD) due to diabetes. Because ESRD is a preventable complication of
diabetes, the association with SES may be related to limited access to treatment.
RESEARCH DESIGN AND METHODS — In this population-based ecological study, I
examined the association between the incidence of ESRD attributed to diabetes and the propor-
tion of hospitalizations with no insurance, Medicaid, or managed care insurance; residence in a
primary care provider shortage area or rural area; and rate of hospitalizations for hyperglycemic
complications, by ZIP code in California in 2001–2004.
RESULTS — The incidence of ESRD attributed to diabetes was higher in ZIP codes with
higher proportions of hospitalizations with no insurance (r  0.45; P  0.0001) or Medicaid
(r  0.69; P  0.0001) and in ZIP codes with higher rates of hospitalizations for hyperglycemic
complications (r  0.27; P  0.0001). The incidence was lower in ZIP codes with higher
proportions of hospitalizations with managed care insurance (r  0.37; P  0.0001) and was
lower in primary care provider shortage areas and rural locations. In contrast, there were only
weak associations between measures of access to care and the incidence of ESRD attributed to
polycystic kidney disease, a condition that is not treatable.
CONCLUSIONS — TheincidenceofESRDattributedtodiabetesisstronglyassociatedwith
area-based measures of access to care, suggesting that access to treatment partly mediates the
association between SES and the incidence of ESRD.
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E
nd-stage renal disease (ESRD), rep-
resenting renal disease severe
enough to require treatment with di-
alysis or renal transplantation, is an in-
creasingly common and costly chronic
disease. In 2006, 110,000 patients be-
gan treatment for ESRD in the U.S., and
ESRD treatment comprised 6.4% of the
Medicare budget (1). Diabetes accounts
for40%ofnewcases,andtheincidence
of ESRD due to diabetes outpaces that of
all other causes of ESRD (1). Identifying
modiﬁable factors that contribute to
ESRD due to diabetes could therefore
have an important impact on the nation’s
health and resource utilization.
Individualsoflowsocioeconomicsta-
tus (SES) have an increased risk of ESRD
(2–4). Those living in the poorest 25% of
neighborhoods in the U.S. have a risk of
ESRD that is 1.2–2.7 times higher than
that of those living in the wealthiest 25%
of neighborhoods (4). However, the
strength of association between SES and
ESRD varies among primary renal dis-
eases. Stronger SES gradients in risk have
beenreportedforESRDduetodiabetesor
hypertension than other causes. These
were presumed to be due to limited avail-
ability of antidiabetic and antihyperten-
sive treatment among persons of lower
SES (3). We recently reported that al-
though SES was strongly associated with
the incidence of ESRD due to diabetes,
therewasaweakerassociationwithESRD
due to lupus nephritis and no association
with ESRD due to autosomal dominant
polycystic kidney disease (ADPCKD) (4).
The contrasting association between SES
and ESRD due to diabetes, which is pre-
ventable (5,6), and SES and ESRD due to
ADPCKD, which is less preventable (7),
suggests that access to effective treatment
may have an important role in mediating
the association between SES and the risk
of ESRD.
In this population-based study, we
examined associations between measures
of access to care and the incidence of
ESRD attributed to diabetes or ADPCKD.
Wehypothesizedthatarea-basedmarkers
of poor access to care would be directly
correlated with the local incidence of
ESRD attributed to diabetes but would
not be related to the local incidence of
ESRD attributed to ADPCKD.
RESEARCH DESIGN AND
METHODS— Thisstudyusedaneco-
logical design in which areal measures of
SES and access to medical care were asso-
ciated with variations in the incidence of
ESRD across small areas. This design was
used because population-based areal
measuresofSES,accesstocare,andESRD
incidence were available, whereas pa-
tient-based measures of SES were not
available. California was studied because
it is the most populous state and because
population-based data on hospitaliza-
tions in California were available. These
hospitalization data provided informa-
tion on medical insurance coverage and
the frequency of admissions for hypergly-
cemic complications, which were used as
measures of access to care. The data
sources included information on county
and ZIP code but not on census tract or
block group. ZIP codes were used as the
area because these were the smallest geo-
graphic units reported. The study was ex-
empted from human subjects review by
the National Institutes of Health Ofﬁce of
Human Subjects Research.
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Data were drawn from ﬁve sources: the
U.S. Renal Data System (USRDS), the
2000U.S.Census,theCaliforniaOfﬁceof
Statewide Health Planning and Develop-
ment patient discharge data ﬁles, the U.S.
Department of Health and Human Ser-
vices Health Resources and Services Ad-
ministrationHealthProfessionalShortage
Area database, and the U.S. Department
ofAgricultureEconomicResearchService
Rural-Urban Commuting Area database.
We used the USRDS, a national pop-
ulation-based registry, to obtain informa-
tion on patients with treated incident
ESRD (1). Patients are enrolled in the
USRDS after being certiﬁed as needing
ongoing renal replacement therapy by
their attending nephrologist. The registry
includes information on patient demo-
graphic characteristics, the primary renal
disease causing ESRD, renal replacement
therapy, and outcomes. We abstracted
data on all patients with incident ESRD
attributed to diabetes or ADPCKD from 1
January 2001 to 30 June 2004 who re-
sided in California. This information in-
cluded patient age, sex, race, and ZIP
codeofresidence.Welimitedtheanalysis
to those aged 20 or older, so that the
group with ESRD attributed to ADPCKD
would not be likely to include patients
with other forms of cystic renal disease.
Of 18,843 patients, we excluded 466
(2.5%) because of missing or invalid ZIP
codes, leaving 18,377 for analysis
(17,605 with diabetes and 772 with
ADPCKD).
We used data from the 2000 U.S.
Census to compute an area-based mea-
sureofSES,basedonsevencharacteristics
of the residents of each ZIP code (log of
median household income, proportion
with income 200% of the federal pov-
erty level, log of median house value, log
of median monthly rent, mean education
level,proportionofindividualsaged25
years who were college graduates, and
proportion of employed persons with a
professional occupation) (4). We com-
puted the mean  SD of each measure
among all ZIP codes and corresponding z




computed as the unweighted sum of the z
scores for all seven measures. The com-
posite SES score correlated well with in-
dividual-leveleducationalattainment(4).
Residents of ZIP codes with an SES score
of 1.11 (20th percentile of the distribu-
tion of ZIP codes in California) had a me-
dian household income of $34,315, 35%
had incomes 200% of the federal pov-
erty level, 12.9% were college graduates,
and 25% had a professional occupation.
Residents of ZIP codes with an SES score
of 6.43 (80th percentile of the distribu-
tion of ZIP codes in California) had a me-
dian household income of $66,873, 12%
had incomes 200% of the federal pov-
erty level, 42.8% were college graduates,
and48.4%hadaprofessionaloccupation.
The California Ofﬁce of Statewide
Health Planning and Development pa-
tient discharge data ﬁles include dis-
charge abstracts for each hospitalization
at all acute-care, nonfederal hospitals in
the state. The abstracts include informa-
tion on patient demographic characteris-
tics, ZIP code of residence, the principal
diagnosis (deﬁned as the condition
chieﬂyresponsibleforthehospitalization,
by ICD-9-CM codes), up to 24 additional
diagnoses, major procedures, and dispo-
sition. The discharge abstracts are pre-
paredfrommedicalandbillingrecordsby
trained abstractors. Data are subjected to
extensive reliability and consistency
checks, and data ﬁelds with error rates of
0.1% or higher are returned to hospitals
for correction (8). Reabstraction studies
that compared these discharge abstracts
with original medical records have found
speciﬁcities for diagnoses of 0.98–1.00
andsensitivitiesof0.88–1.00(9).Theav-
erage number of hospitalizations in the
data ﬁles was 3.9 million annually.
We used hospitalization data from
January2001toJune2004toderivethree
measures of medical insurance coverage.
For each ZIP code, we computed the pro-
portion of hospitalizations among resi-
dentsaged20yearsforwhichtherewas
noinsurance,Medicaidcoverage,orman-
aged care insurance. We also computed
the rate of hospitalizations among resi-
dents aged 20 for which a hyperglyce-
mic complication (ketoacidosis or
hyperosmolar coma, by ICD-9-CM
codes) was the reason for admission and
used this as a measure of access to care
that was speciﬁc to diabetes (10,11). In
addition, we computed the rate of lower-
extremity amputations in patients with
diabetes among residents aged 20 years
by ZIP code, as a comparison condition
for ESRD caused by diabetes.
We used the Health Resources and
Services Administration Health Profes-
sional Shortage Area database to identify
census tracts in California that had been
designated as primary care shortage areas
at any time from January 2001 to June
2004(12).Amongthecriteriaforthisdes-
ignation is a population–to–primary care
physician ratio of 3,500:1 and barriers
toaccessingcareinneighboringareas.We
mapped these census tracts to ZIP codes
andclassiﬁedeachZIPcodeeitherashav-
ing ever or never been a primary care
shortagearea.Lastly,weusedtheU.S.De-
partment of Agriculture Rural-Urban
CommutingAreadatabasetoclassifyeach




dependent variables were the incidences
of ESRD caused by either diabetes or
ADPCKD. Incidences were standardized to
the age (10-year groups), sex, and race
distribution of the California population
in 2000 using direct standardization. We
used Pearson correlations to examine
associations between the incidences and
the SES score, the insurance measures,
and rates of hospitalizations for hypergly-
cemiccomplications.Theseanalyseswere
weighted by the population in each ZIP
code so that more populous ZIP codes
contributed more to the associations than
sparsely populated ZIP codes. We used
unweighted t tests to compare incidences
between ZIP codes that were in primary
care shortage areas and those that were
not and between rural and urban ZIP
codes. We repeated the analyses using rates
of hospitalizations for lower-extremity
amputation in patients with diabetes as
the dependent variable.
Next, we used weighted multiple re-
gression models to examine the extent to
which measures of access to care de-
creased the association between the SES
score and the incidence of ESRD. In these
models, incidence was the dependent
variable, and the SES score, insurance
variables,hospitalizationsforhyperglyce-
mic complications, and rural location
were the independent variables. Residual
analysis showed no deviations from nor-
mality, and there was no evidence of multi-
collinearity in the models. One inﬂuential
observation was present in the model pre-
dictingESRDattributedtodiabetes;exclud-
ing this observation changed the
standardized  coefﬁcients by 0.03 and
did not alter the signiﬁcance tests. Analyses
were performed using SAS programs (ver-
sion 9.1, SAS, Cary, NC). All hypothesis
tests were two-tailed, and P  0.05 was
considered statistically signiﬁcant.
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Measures of access to care
Among 1,681 ZIP codes, the population
aged 20 years ranged from 3 to 64,517,
with a mean of 13,515. The SES scores
ranged from 17.1 to 18.0 among ZIP
codes, compared with the national aver-
age SES score of 0, indicating representa-
tion of both very poor and very wealthy
neighborhoods. The proportion of acute-
care hospitalizations for which there was
no insurance ranged from 0 to 50%
among ZIP codes (mean 2%), the propor-
tion with Medicaid ranged from 0 to
100% (mean 17%), and the proportion
withmanagedcareinsurancerangedfrom
0 to 83% (mean 24%). Of the ZIP codes,
117(7%)wereinfederallydesignatedpri-
mary care Health Professional Shortage
Areasand242(14%)wererural.Overthe
3.5-year study period, there were 16,553
hospitalizations for hyperglycemic com-
plications in patients aged 20 years,
with annual rates that ranged from 0 to
9,260 hospitalizations per million across
ZIP codes.
Associations with ESRD attributed
to diabetes
The average annual incidence of ESRD at-
tributed to diabetes was 236 per million
persons, with a range from 0 to 3,258 per
million among ZIP codes. Incidences
were inversely related with the composite
SES score, with higher incidences in ZIP
codes with lower SES (Table 1). Inci-
dences were highly correlated with all
threeinsurancemeasures,beinghigherin
ZIP codes with a greater proportion of hos-
pitalizations with Medicaid or no insurance
coverage and lower in ZIP codes with a
greater proportion of hospitalizations with
managed care coverage. Incidences were
alsohigherinZIPcodeswithhigherratesof
hospitalizations for hyperglycemic compli-
cations. However, incidences were lower in
ZIP codes in primary care Health Profes-
sional Shortage Areas (mean 162 per mil-
lion) than in ZIP codes not in these areas
(mean 241 per 100,000) (t  2.07; P 
0.04). Incidences were also lower in rural
(mean 123 per million) than in urban ZIP
codes (mean 258 per million) (t  4.85;
P  0.0001).
In a multivariate analysis that in-
cluded the SES score, the insurance mea-
sures, rate of hospitalizations for
hyperglycemic complications, and rural
location, the variation in incidence of
ESRD attributed to diabetes was signiﬁ-
cantly associated with the SES score and
the proportion of hospitalizations with
Medicaid coverage in the ZIP code (Table
2). The model R
2 was 0.48. Compared
with a model that included the SES score
as the only independent variable, the ad-
dition of the measures of access to care
reduced the association of the SES score
with the incidence of ESRD caused by di-
abetes by 86% (standardized  for SES
score in the univariate model  0.55;
standardized  for SES score in the mul-
tivariate model  0.074).
Associations with ESRD attributed
to ADPCKD
The average annual incidence of ESRD at-
tributed to ADPCKD was 10 per million
persons, with a range from 0 to 1,340 per
million among ZIP codes. In contrast to
ESRD attributed to diabetes, there was no
association between the incidence of
ESRD attributed to ADPCKD and SES
score, and only weak associations with
theproportionofhospitalizationswithno
insurance or Medicaid (Table 1). There
was also no difference in incidence be-
tween ZIP codes in primary care Health
Professional Shortage Areas (mean 8.7
per million) and ZIP codes not in these
areas (mean 10.3 per million) (t  0.32;
P  0.76) or between rural (mean 9.9 per
million) and urban (mean 10.3 per mil-
lion) ZIP codes (t  0.11; P  0.92). No
measuresofaccesstocarewereassociated
Table1—CorrelationsbetweenZIPcode–basedmeasuresofaccesstocareandtheincidenceofESRDattributedtodiabetesorADPKDandthe








r P rPr P
SES score* 0.55 0.0001 0.04 0.09 0.51 0.0001
Proportion of hospitalizations with no insurance 0.45 0.0001 0.06 0.02 0.33 0.0001
Proportion of hospitalizations with Medicaid 0.69 0.0001 0.05 0.03 0.45 0.0001
Proportion of hospitalizations with managed care insurance 0.37 0.0001 0.01 0.77 0.36 0.0001
Rate of hospitalizations for hyperglycemic complications 0.27 0.0001 — — 0.46 0.0001
Correlations were weighted by the population of each ZIP code. *Higher scores indicate wealthier areas.
Table2—AssociationofmeasuresofaccesstocareandtheincidenceofESRDattributedtodiabetesorADPKDbymultipleregressionanalysis
ESRD attributed to diabetes ESRD attributed to ADPKD
Standardized  tP Standardized  tP
SES score* 0.074 2.47 0.02 0.018 0.44 0.67
Proportion of hospitalizations with no insurance 0.018 0.79 0.44 0.047 1.46 0.15
Proportion of hospitalizations with Medicaid 0.641 20.1 0.0001 0.042 0.96 0.34
Proportion of hospitalizations with managed care insurance 0.014 0.66 0.52 0.035 1.16 0.25
Rate of hospitalizations for hyperglycemic complications 0.025 1.25 0.22 0.03 1.04 0.30
Rural location 0.035 1.96 0.06 0.009 0.38 0.71
*Higher scores indicate wealthier areas.
Access to care and ESRD in diabetes
1034 DIABETES CARE, VOLUME 32, NUMBER 6, JUNE 2009with variations in the incidence of ESRD
attributed to ADPCKD in a multivariate
model (Table 2).
Associations with rates of lower-
extremity amputation in patients
with diabetes
Over the 3.5-year study period, there
were 9,892 hospitalizations among pa-
tients with diabetes in which a lower-
extremity amputation was performed as
the primary procedure of the hospitaliza-
tion. The annual rate ranged from 0 to
1,078 hospitalizations per million per-
sons among ZIP codes. Rates were highly
correlatedwiththeSESscore,theinsurance
measures,andtherateofhospitalizationfor
hyperglycemic complications (Table 1).
Rates of lower-extremity amputations were
somewhat less strongly associated with the
proportion of hospitalizations with Medic-
aidornoinsurancecoverageandsomewhat
more strongly associated with hospitaliza-
tions for hyperglycemic complications than
was the incidence of ESRD attributed to di-
abetes. The incidence of ESRD attributed to
diabeteswascorrelatedwiththerateofhos-
pitalizations for lower-extremity amputa-
tions among ZIP codes (weighted r0.41;
P  0.0001).
CONCLUSIONS — Diabetes is the
most common cause of ESRD in the U.S.
(1). Understanding and remedying the
factors that contribute to the risk of ESRD
due to diabetes can therefore have an im-
portant impact on the overall morbidity
and costs of ESRD. SES is probably one of
these factors. If persons living in poorer
neighborhoodshadthesameriskasthose
living in the wealthiest 25% of neighbor-
hoods, there would be 10,000 fewer
new cases of ESRD due to diabetes in the
U.S. annually (8). However, association
does not necessarily indicate causation,
and possible mechanisms by which SES
or its correlates may act to inﬂuence the
risk of ESRD remain undeﬁned.
One potentially important mecha-
nism is access to effective treatment. In
this study, we found strong correlations
betweentheincidenceofESRDattributed
todiabetesandmeasuresofinsurancesta-
tus. At the group level, the incidence of
ESRD was higher in areas with poorer ﬁ-
nancial access to care. The incidence was
also higher in areas with more hospital-
izationsforhyperglycemiccomplications,
indicating that poorer diabetes-speciﬁc
care was associated with higher rates of
ESRD caused by diabetes. Adjusting for
these measures of access to care greatly
decreased the association between the in-
cidence of ESRD and the area-based mea-
sure of SES, suggesting that ﬁnancial
access to care mediates this association in
part. In contrast, there was comparably
little association between measures of ac-
cess to care and the incidence of ESRD
attributed to ADPCKD. This ﬁnding was
predicted based on the absence of associ-
ation between SES and the risk of ESRD
due to ADPCKD (4) and current treat-
ment options for this condition. The par-
allel associations between SES and
measures of access to care in these two
conditions also suggest that access to care
is an important mechanism by which SES
is related to the incidence of ESRD.
Limited access to care may result in
delayed diagnosis of diabetes, inadequate
education in diet and self-care, inade-
quate access to medications or monitor-
ing, and suboptimal treatment and
follow-up. Previous studies of the associ-
ation between access to care and health
outcomes in patients with diabetes have
focusedonmedicalinsurancestatus.Lack
of medical insurance and, in some stud-
ies, lack of private medical insurance cov-
erage have been associated with higher
levels of A1C, higher prevalences of albu-
minuria, inconsistent use of antidiabetic
medications,andlowerfrequenciesofmon-
itoring for diabetes complications (14–17).
Not having a regular source of care has also
been associated with higher levels of A1C
(14,17). These limitations, if sustained, can
increase the likelihood of ESRD. Con-
versely,areaswithhighproportionsofman-
aged care coverage in our study had lower
rates of ESRD due to diabetes, suggesting
that participation in systems emphasizing
preventive care had beneﬁcial effects on
health outcomes. This ﬁnding is consistent
with the observation that among enrollees
in the Kaiser Permanente health mainte-
nance organization, there was no associa-
tion between SES and the incidence of
ESRD due to diabetes, probably because
SES-associated ﬁnancial barriers to care
were not present (18).
Previous studies have reported that
areas with lower densities of physicians
have higher rates of all-cause ESRD (19),
but studies have not examined whether
areas meeting the criterion of primary
care provider shortage areas have rates of
ESRD that differ from those of areas with-
out provider shortages. Primary care
provider shortages represent an organiza-
tionalbarriertocareandhavebeenlinked
with both poorer quality of care and
poorer health status among patients with
diabetes (20). However, in this study,
rates of ESRD attributed to diabetes were
lower in areas designated as having short-
ages in primary care providers compared
with areas not having shortages. Simi-
larly, rates were lower in rural than in ur-
ban ZIP codes. Patients with a chronic
conditionsuchasdiabetesmayhavebeen
betterabletosecureprovidersdespiteliv-
ing in a shortage area or rural area. The
importance of education and self-care in
the development of diabetes complica-
tions may have mitigated the inﬂuence of
livingintheseareas.Itisalsopossiblethat
patients with severe diabetes moved out
of shortage areas or into towns or cities in
anticipation of the need for better access
to care, thereby lowering rates of ESRD in
these areas. Some misclassiﬁcation may
also have occurred because we classiﬁed
ZIP codes as shortage areas if at any time
duringthe3.5-yearstudyperiodtheyhad
been designated a shortage area. Rates of
ESRD attributed to ADPCKD did not dif-
fer by shortage area or rural/urban loca-
tion, suggesting that these geographic
differenceswereduetofactorsspeciﬁcally
associated with diabetes.
The association between access to
care and health outcomes in patients with
diabetes was not unique to ESRD. Similar
associationswerefoundforratesoflower-
extremityamputations.Theriskoflower-
extremity amputation in patients with
diabetes has been associated with poor
glycemic control and, although studied
less extensively, poorer quality of care
(21,22). These ﬁndings suggest that ac-
cess to care may also have an important
role in the risk of lower-extremity ampu-
tation. Together, these results provide
convergent validity for the association of
measures of access to care with the risk of
ESRD attributed to diabetes.
Despite its importance, limited ﬁnan-
cial access to care is probably not the only
mechanism by which SES is associated
with increased rates of ESRD. Among pa-
tients treated in the Department of Veter-
ans Affairs health care system or in
managed care organizations, poorer and
less well-educated patients had poorer
glycemic control and lower adherence to
self-care recommendations than wealth-
ier or more well-educated patients
(23,24). SES-related differences in diabe-
tes-speciﬁc knowledge, motivation,
health beliefs, social support, and com-
peting priorities may account for some of
these SES associations. However, medical
insurance remains an important precon-
dition enabling access to care.
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the large population-based samples, the
inclusion of several different measures of
access to care, and the contrasts between
two primary renal diseases that differ in
their associations with SES. However, the
studyisecological,andassociationsatthe
group level may not apply to individual
patients. Cohort studies that assessed the
association between barriers to care, SES,
and the progression to ESRD among pa-
tients with different primary renal dis-
eases would be needed to examine these
associations at the individual level. Only
one organizational barrier to care was
studied, as area-level data on distances
traveled to receive care, wait times, or
other measures of access were not avail-
able. However, rural/urban location was
used as a surrogate of distance traveled to
obtain care. Although the incidences of
ESRD were adjusted for race, we do not
know whether the SES associations with
ESRD varied by race or ethnicity. Seventy
percent of patients with ESRD attributed
to diabetes were white, as were 83%
of patients with ESRD attributed to
ADPCKD. There were too few patients of
other racial groups to perform compara-
tive analyses stratiﬁed by race or ethnic-
ity. Cultural differences in health care
utilization may interact with barriers to
care to affect health outcomes and may
either exaggerate or diminish the con-
trasts between ESRD attributed to diabe-
tes and ESRD attributed to ADPCKD
reported here. The study was limited to
adults in California, and associations may
differ in children or in other states.
Socioeconomic disparities are more
pronounced for conditions that have ef-
fective treatments and for which there are
socioeconomicbarrierstoaccessingtreat-
ment (25). The results of this study indi-
cate that access to care for treatable
conditions is an important factor inﬂu-
encing rates of ESRD and mediating SES-
associated differences in rates. Efforts to
decrease rates of ESRD and to decrease
socioeconomic disparities in ESRD inci-
dence should include an emphasis on en-
suringaccesstocarebeforecomplications
such as ESRD occur.
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